AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Daily Turnover | The turnover of Penumbra on 7/16 was $125.46 Million, Ranking 725
ByAinvest
Wednesday, Jul 16, 2025 6:20 pm ET1min read
The turnover of Penumbra on 7/16/2025 was $125.46 million, ranking 725 in today's market, the Volume is 0.53 million.
Penumbra(PEN) shares closed at $234.41, down 0.85% on 7/16/2025, down 4.08% in the last 5 trading days, down 8.66% this month, down 1.29% year-to-date and up 15.35% in the last 52 weeks.
*If the company has been listed for less than 52 weeks, the 52-week gain is the gain since the listing.
(The same applies for less than 1 month, or less than 5 trading days)
【History Turnover】
| Date | Turnover | Volume | Price | Performance |
|---|---|---|---|---|
| 7/16/2025 | $125.46 million | 0.53 million | $234.41 | -0.85% |
| 7/15/2025 | $135.97 million | 0.57 million | $236.41 | -1.22% |
| 7/14/2025 | $95.06 million | 0.40 million | $239.32 | 0.58% |
| 7/11/2025 | $89.82 million | 0.38 million | $237.94 | -2.43% |
| 7/10/2025 | $87.71 million | 0.36 million | $243.87 | -0.21% |
【Company Profile】
Penumbra, Inc. was incorporated in 2004 as a Delaware corporation.The company is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that its products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc's editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet